A COVID-19 perspective of Vogt-Koyanagi-Harada disease
Vogt-Koyanagi-Harada (VKH) disease, a bilateral granulomatous panuveitis associated with multisystem involvement, is a T-cell-mediated autoimmune disorder in which cytotoxic T-cell target melanocytes in genetically susceptible individuals. Recently, there has been an increase in literature on the new onset of uveitis and reactivation of previously diagnosed cases of uveitis following Covid-19 vaccinations. It has been postulated that Covid-19 vaccines can lead to an immunomodulatory change resulting in an autoimmune phenomenon in the recipients. VKH following COVID-19 infection was reported in four patients and a total of 46 patients developing VKH or VKH-like disease following COVID-19 vaccinations. There are reports of four patients who had been recovering or recovered from VKH after receiving the first dosage of the vaccine and developed worsening of ocular inflammation after receiving the second dose of the vaccine.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:71 |
|---|---|
| Enthalten in: |
Indian journal of ophthalmology - 71(2023), 6 vom: 01. Juni, Seite 2587-2591 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Dutta Majumder, Parthopratim [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adverse reaction |
|---|
| Anmerkungen: |
Date Completed 19.06.2023 Date Revised 16.11.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4103/IJO.IJO_172_23 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM35824272X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM35824272X | ||
| 003 | DE-627 | ||
| 005 | 20231226074328.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4103/IJO.IJO_172_23 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1194.xml |
| 035 | |a (DE-627)NLM35824272X | ||
| 035 | |a (NLM)37322685 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Dutta Majumder, Parthopratim |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A COVID-19 perspective of Vogt-Koyanagi-Harada disease |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 19.06.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Vogt-Koyanagi-Harada (VKH) disease, a bilateral granulomatous panuveitis associated with multisystem involvement, is a T-cell-mediated autoimmune disorder in which cytotoxic T-cell target melanocytes in genetically susceptible individuals. Recently, there has been an increase in literature on the new onset of uveitis and reactivation of previously diagnosed cases of uveitis following Covid-19 vaccinations. It has been postulated that Covid-19 vaccines can lead to an immunomodulatory change resulting in an autoimmune phenomenon in the recipients. VKH following COVID-19 infection was reported in four patients and a total of 46 patients developing VKH or VKH-like disease following COVID-19 vaccinations. There are reports of four patients who had been recovering or recovered from VKH after receiving the first dosage of the vaccine and developed worsening of ocular inflammation after receiving the second dose of the vaccine | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Adverse reaction | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a Covid-19 vaccine | |
| 650 | 4 | |a Vogt–Koyanagi–Harada disease | |
| 650 | 4 | |a corticosteroid | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Sadhu, Soumen |e verfasserin |4 aut | |
| 700 | 1 | |a González-López, Julio J |e verfasserin |4 aut | |
| 700 | 1 | |a Mochizuki, Manabu |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Indian journal of ophthalmology |d 1971 |g 71(2023), 6 vom: 01. Juni, Seite 2587-2591 |w (DE-627)NLM000735493 |x 1998-3689 |7 nnns |
| 773 | 1 | 8 | |g volume:71 |g year:2023 |g number:6 |g day:01 |g month:06 |g pages:2587-2591 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4103/IJO.IJO_172_23 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 71 |j 2023 |e 6 |b 01 |c 06 |h 2587-2591 | ||